Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q4 2021
Institutional positions in Verona Pharma plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +2 vs. Q3 2021
- Shares held
- 36.9M
- −82.6K (−0.2%) vs. Q3 2021
- Total value
- $248.0M
- +$45.3M (+22.3%) vs. Q3 2021
- New holders
- 9
- 6 more added
- Sold out
- 7
- 8 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 5,694,841 | $38.3M | 0.50% | 00.0% | Unchanged |
| NEA Management Company, LLC | 5,108,563 | $34.3M | 0.69% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 5,100,000 | $34.3M | 0.60% | 00.0% | Unchanged |
| Wellington Management Group LLP | 4,831,988 | $32.5M | 0.01% | +537,950+12.5% | Added |
| Perceptive Advisors LLC | 2,867,510 | $19.3M | 0.30% | −21,379−0.7% | Reduced |
| Vivo Capital, LLC | 2,749,918 | $18.5M | 1.11% | 00.0% | Unchanged |
| Abingworth LLP | 2,457,499 | $16.3M | 3.95% | 00.0% | Unchanged |
| Aisling Capital Management LP | 1,332,485 | $8.95M | 3.16% | 00.0% | Unchanged |
| Foresite Capital Management III, LLC | 1,111,112 | $7.47M | 18.90% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,111,112 | $7.47M | 1.49% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 926,602 | $6.23M | 2.05% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 801,256 | $5.38M | 0.64% | 00.0% | Unchanged |
| Novo Holdings A/S | 761,205 | $5.12M | 0.24% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 751,905 | $5.05M | 0.16% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 750,000 | $5.04M | 1.93% | 00.0% | Unchanged |
| venBio Partners LLC | 161,897 | $1.09M | 0.20% | 00.0% | Unchanged |
| Logos Global Management LP | 122,000 | $820.0K | 0.08% | +122,000 | New |
| Schonfeld Strategic Advisors LLC | 58,000 | $390.0K | 0.00% | −600−1.0% | Reduced |
| D.A. Davidson & Co. | 48,000 | $323.0K | 0.00% | +8,000+20.0% | Added |
| Forefront Analytics, LLC | 34,106 | $229.0K | 0.08% | +950+2.9% | Added |
| Susquehanna International Group, LLP | 30,780 | $207.0K | 0.00% | +15,416+100.3% | Added |
| Millennium Management LLC | 15,969 | $107.0K | 0.00% | +1,183+8.0% | Added |
| HSBC Holdings PLC | 15,041 | $102.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 13,273 | $89.0K | 0.00% | +2,566+24.0% | Added |
| Marshall Wace, LLP | 12,263 | $82.0K | 0.00% | +12,263 | New |
| Citadel Advisors LLC | 11,889 | $80.0K | 0.00% | −10,981−48.0% | Reduced |
| Rathbone Brothers plc | 11,959 | $80.0K | 0.00% | 00.0% | Unchanged |
| IPG Investment Advisors LLC | 11,900 | $80.0K | 0.01% | +11,900 | New |
| Lindbrook Capital, LLC | 10,000 | $67.0K | 0.01% | +10,000 | New |
| Morgan Stanley | 7,268 | $48.0K | 0.00% | −926−11.3% | Reduced |
| Simplex Trading, LLC | 4,372 | $29.0K | 0.00% | +4,372 | New |
| US Bancorp | 3,840 | $26.0K | 0.00% | 00.0% | Unchanged |
| Endurance Wealth Management, Inc. | 2,000 | $13.0K | 0.00% | +2,000 | New |
| Bank of America Corp | 992 | $7.00K | 0.00% | −10,078−91.0% | Reduced |
| Fifth Third Bancorp | 1,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Migdal Insurance & Financial Holdings Ltd. | 826 | $6.00K | 0.00% | −498−37.6% | Reduced |
| Plante Moran Financial Advisors, LLC | 892 | $6.00K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 726 | $5.00K | 0.00% | −3,689−83.6% | Reduced |
| CoreCap Advisors, LLC | 600 | $4.00K | 0.00% | +600 | New |
| Tower Research Capital LLC (TRC) | 333 | $2.00K | 0.00% | −1,444−81.3% | Reduced |
| BNP Paribas Arbitrage, SA | 238 | $1.60K | 0.00% | +238 | New |
| Group One Trading, L.P. | 79 | $1.00K | 0.00% | +79 | New |
| Citigroup Inc | 0 | $0 | 0.00% | −495,446−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −245,594−100.0% | Sold out |
| IHT Wealth Management, LLC | 0 | $0 | 0.00% | −18,560−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −879−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −59−100.0% | Sold out |